ARKG Holdings of Vertex Pharmaceuticals (VRTX) - Updated Daily

TherapeuticsGene TherapyGenomicsCRSPR Gene Editing

Shares HeldWeight In Fund

Trades of VRTX Made In ARKG

Why do the number of shares of a company held in an ARK ETF go up or down even when no trades are reported?

Date	Direction	Shares	Fund Weight	Fund

November 15, 2024	SELL	6.421k	0.2392%	ARKG
November 6, 2024	SELL	5.292k	0.2062%	ARKG
October 25, 2024	SELL	505.000	0.0205%	ARKG
October 24, 2024	SELL	5.008k	0.1985%	ARKG
October 8, 2024	SELL	566.000	0.0201%	ARKG

Statistics

Ticker	Name	Weight

IBB	iShares Biotechnology ETF	7.42%
GNOM	Global X Genomics & Biotechnology ETF	2.17%
ARKG	ARK Genomic Revolution ETF	1.98%
XLV	Health Care Select Sector SPDR® Fund	1.68%
XBI	SPDR® S&P Biotech ETF	1.09%
QYLD	Global X NASDAQ 100 Covered Call ETF	0.66%
QQQ	Invesco QQQ Trust	0.64%
SPY	SPDR S&P 500 ETF Trust	0.24%
LABU	S&P Biotech Bull 3X Shares ETF	0.238%

No Research Notes Found for VRTX